Back to Search
CHRISTOPHER BERKERS, DMD
DMD
General Practice Dentistry
NPI: 1790814135Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
5327-015(WI)
Research & Publications (13)
Transpeptidation and reverse proteolysis and their consequences for immunity.
PMID 18817889·Int J Biochem Cell Biol·2009
6-review
Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.
PMID 19332645·FASEB J·2009
7-preclinical
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
PMID 18308940·Proc Natl Acad Sci U S A·2008
8-other
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
PMID 18057228·Blood·2008
7-preclinical
Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity.
PMID 18534969·Mol Cell Proteomics·2008
7-preclinical
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.
PMID 18565852·Blood·2008
8-other
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.
PMID 17024115·Leukemia·2007
7-preclinical
A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.
PMID 17114003·Chem Biol·2006
7-preclinical
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.
PMID 16531229·Structure·2006
7-preclinical
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
PMID 16286248·Cancer Cell·2005
4-observational
Immunotherapeutic potential for ceramide-based activators of iNKT cells.
PMID 15860372·Trends Pharmacol Sci·2005
6-review
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.
PMID 15846363·Nat Methods·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 451 E BROOKLYN ST STE 1
CHILTON, WI 53014 - Phone
- (920) 849-9667
Quick Facts
- NPI
- 1790814135
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile